Skip to Main Content

Paper Details

Direct early growth response-1 knockdown decreases melanoma viability independent of mitogen-activated extracellular signal-related kinase inhibition.
0
2023
-, 1, DMSO, EGR1, MEK, MEK inhibitor-treated cells, MEL624, MEL888, RNA, YUARGE 13-3064, YUARGE-, conjunctival, conjunctival (YUARGE 13-3064) melanoma cell line, conjunctival melanoma, cutaneous, cutaneous and conjunctival melanoma, early growth, early growth response-, early growth response-1, inhibitor, malignant melanoma, malignant melanoma cell population, melanoma, melanoma cell culture, melanoma cell lines, melanoma cells, mitogen-activated extracellular signal-related kinase, mitogen-activated protein kinase, shRNA, trametinib, treated cells

Datasets

Release 1.2